输血相关循环超负荷临床诊治的专家共识（2026版）

doi:10.3969/j.issn.1671-2587.2026.01.001

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (1): 1-8.DOI: 10.3969/j.issn.1671-2587.2026.01.001

• 专家共识 • 下一篇

输血相关循环超负荷临床诊治的专家共识（2026版）

中国输血协会临床输血学专业委员会《输血相关循环超负荷临床诊治的专家共识（2026版）》编写组

收稿日期:2026-01-01 发布日期:2026-02-13
通讯作者: 执笔：周吉成（河池市第一人民医院血液科、河池市血液病防治重点实验室、广西医科大学第一附属医院血液科，（E-mail）z1964jc@126.com。）

Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-associated Circulatory Overload (2026 Edition)

Writing Group of Expert Consensus on the Clinical Diagnosis, Treatment of Transfusion-associated Circulatory Overload, Working Party on Clinical Transfusion, Chinese Society of Blood Transfusion

Received:2026-01-01 Published:2026-02-13

摘要/Abstract

摘要： 输血相关循环超负荷（transfusion-associated circulatory overload, TACO）是一种严重的输血并发症。中国输血协会临床输血学专业委员会组织我国包括输血科、血液科、心血管内科、呼吸科及重症医学科等领域的专家学者制订了《输血相关循环超负荷临床诊治的专家共识（2026版）》，该共识就TACO相关的辅助检查、诊断与鉴别诊断、预防及治疗策略提出了专家共识意见，以便进一步提高我国TACO的诊治水平。

关键词: 输血相关循环超负荷, 血液成分, 肺水肿, 呼吸困难

Abstract: Transfusion-associated circulatory overload (TACO) is a severe transfusion complication. The Working Party on Clinical Transfusion, Chinese Society of Blood Transfusion (CSBT) organized domestic experts and scholars from disciplines including transfusion medicine, hematology, cardiology, pulmonology, and critical care medicine to formulate the Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-Associated Circulatory Overload (2026 Edition). This consensus puts forward expert recommendations on TACO-related auxiliary examinations, diagnosis and differential diagnosis, prevention, and treatment strategies, aiming to further improve the standard of TACO diagnosis and treatment in China.

Key words: Transfusion-associated circulatory overload, Blood components, Pulmonary edema, Dyspnea

中图分类号:

R457

中国输血协会临床输血学专业委员会《输血相关循环超负荷临床诊治的专家共识（2026版）》编写组. 输血相关循环超负荷临床诊治的专家共识（2026版）[J]. 临床输血与检验, 2026, 28(1): 1-8.

Writing Group of Expert Consensus on the Clinical Diagnosis, Treatment of Transfusion-associated Circulatory Overload, Working Party on Clinical Transfusion, Chinese Society of Blood Transfusion. Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-associated Circulatory Overload (2026 Edition)[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2026, 28(1): 1-8.

参考文献

[1] BULLE E B,KLANDERMAN R B,DE WISSEL M B, et al. The effect of plasma transfusion in an experimental two-hit animal model of transfusion-associated circulatory overload with heart failure[J]. Blood Transfus, 2023,21(3):218-226.
[2] SCHIPPERUS M R,WIERSUM-OSSELTON J C. Updated definitions for respiratory complications of blood transfusion[J]. Transfusion,2019,59(7):2482-2483.
[3] Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention. National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol[EB/OL]. (2022-02-11). https://www.cdc.gov/nhsn/pdfs/biovigilance/bv-hv-protocol-current.pdf.
[4] International Society of Blood Transfusion Working Party on Haemovigilance. Transfusion-associated circulatory overload (TACO) definition.2018 [cited 2021 Jul 24]. Available from: https://www.isbtweb.org/resource/tacodefinition.html.
[5] JHA S,PATEL K V,BUKHARI A.Chronicle of hypoxemia: transfusion-associated circulatory overload versus transfusion-related acute lung injury[J]. Cureus, 2022,14(9):e28712.
[6] Narayan S, editor, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The2019 Annual SHOT Report[EB/OL].[2025-12-13]. https://www.shotuk.org/wp-content/uploads/myimages/SHOT-REPORT-2019-Final-Bookmarked-v2.pdf.
[7] US Food and Drug Administration. Fatalities Reported to FDA Following Blood Collection and Transfusion Annual Summary for FY2019[EB/OL].[2025-12-13]. https://www.fda.gov/media/147628/download.
[8] BOSBOOM J J,KLANDERMAN R B,MIGDADY Y,et al.Transfusion-associated circulatory overload: a clinical perspective[J]. Transfus Med Rev,2019,33(2):69-77.
[9] BOSBOOM J J,KLANDERMAN R B,ZIJP M,et al.Incidence,risk factors,and outcome of transfusion-associated circulatory overload in a mixed intensive care unit population: a nested case-control study[J]. Transfusion,2018,58(2):498-506.
[10] GOEL R,TOBIAN A A R,SHAZ B H. Noninfectious transfusion-associated adverse events and their mitigation strategies[J]. Blood,2019,133(17):1831-1839.
[11] ROUBINIAN N H,HENDRICKSON J E,TRIULZI D J, et al.Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm[J]. Vox Sang,2017,112(1):56-63.
[12] United States Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year2017[EB/OL].(2022-01-06). https://www.fda.gov/media/124796/download.
[13] 梁春艳,段莉,刘友迎,等. 住院患者输血相关循环超负荷的危险因素及预测模型的构建与验证[J]. 临床输血与检验,2024,26(6):771-776.
[14] 唐聪海,黄燕雪,林艺璇,等. 输血不良反应相关因素分析[J]. 中国实验血液学杂志,2020,28(3):972-976.
[15] YUAN Y,DENNINGTON P M,DALY J,et al.The impact of revised definitions for transfusion-associated circulatory overload and transfusion-related acute lung injury on haemovigilance reporting[J]. Vox Sang, 2023,118(3):199-206.
[16] VAN DEN AKKER T A,GRIMES Z M,FRIEDMAN M T. Transfusion-associated circulatory overload and transfusion-related acute lung injury[J]. Am J Clin Pathol,2021,156(4):529-539.
[17] ROUBINIAN N.TACO and TRALI: biology,risk factors,and prevention strategies[J]. Hematology Am Soc Hematol Educ Program,2018,2018(1):585-594.
[18] 《输血相关急性肺损伤诊治中国专家共识》编写组,周吉成,于洋,等. 输血相关急性肺损伤诊治中国专家共识(2023版)[J]. 临床输血与检验,2023,25(5):577-585.
[19] SEMPLE J W,REBETZ J,KAPUR R.Transfusion-associated circulatory overload and transfusion-related acute lung injury[J]. Blood,2019,133(17):1840-1853.
[20] ROUBINIAN N H,TRIULZI D J.Transfusion-associated circulatory overload and transfusion-related acute lung injury: etiology and prevention[J]. Hematol Oncol Clin North Am,2019,33(5):767-779.
[21] 葛均波,王辰,王建安主编. 内科学[M].10版.北京:人民卫生出版社,2024.
[22] 中国医疗保健国际交流促进会急诊医学分会,中华医学会急诊医学分会,中国医师协会急诊医师分会,等. 急性心力衰竭中国急诊管理指南(2022)[J]. 临床急诊杂志, 2022,23(08):519-547.
[23] ESPINOSA A,GARVIK L J,TRUNG NGUYEN N,et al.A fatal case of acute hemolytic transfusion reaction caused by anti-Wr(a): case report and review of the literature[J]. Immunohematology,2021,37(1):20-24.
[24] JOHNSON-ARBOR K,GILSTAD C,VERSTRAETE R.A potential food-related acute allergic transfusion reaction[J]. Blood Transfus,2024,22(4):367-368.
[25] WEBB C,NORRIS A,HANDS K.An acute transfusion reaction[J]. Clin Med,2018,18(1):95-97.
[26] TACQUARD C,BOUDJEDIR K,CARLIER M,et al.Hypersensitivity transfusion reactions due to IgA deficiency are rare according to French hemovigilance data[J]. J Allergy Clin Immunol,2017,140(3):884-885.
[27] WIERSUM-OSSELTON J C,WHITAKER B,GREY S, et al. Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study[J]. Lancet Haematol,2019,6(7): e350-e358.
[28] NISHIKIMI T,NAKAGAWA Y.Potential pitfalls when interpreting plasma BNP levels in heart failure practice[J]. J Cardiol,2021,78(4):269-274.
[29] RICHARDS A M.BNP as a biomarker in adult congenital heart disease: help or hype?[J]. Eur Heart J, 2024,45(23):2076-2078.
[30] AMMAR L A,MASSOUD G P,CHIDIAC C,et al.BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: A systematic review and meta-analysis[J]. Heart Fail Rev, 2025,30(1):45-54.
[31] KLANDERMAN R B,BOSBOOM J J,MIGDADY Y,et al.Transfusion-associated circulatory overload-a systematic review of diagnostic biomarkers[J]. Transfusion,2019, 59(2):795-805.
[32] MCDONAGH TA,METRA M,ADAMO M,et al.2021 ESC Guidelines for thediagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J,2021,42(36): 3599-3726.
[33] SMITH C M.CE: recognizing transfusion-associated circulatory overload[J]. Am J Nurs,2023,123(11):34-41.
[34] SONI L,SAEED S,CSERTI-GAZDEWICH C,et al.Mortality-associated risk factors for transfusion-associated circulatory overload[J]. Vox Sang,2024,119(9):996-1000.
[35] VAN WONDEREN S F,KLANDERMAN R B,VLAAR A P J. Understanding transfusion-related acute lung injury (TRALI) and its complex pathophysiology[J]. Blood Transfus,2022,20(6):443-445.
[36] GOGOS C,STAMOS K,TSANAXIDIS N,et al.Blood transfusion components inducing severe allergic reactions: the first case of kounis syndrome induced by platelet transfusion[J]. Vaccines,2023,11(2):220.
[37] BADAMI K G,JOLIFFE E,STEPHENS M.Transfusion-associated dyspnea—shadow or substance?[J]. Vox Sang,2015,109(2):197-200.
[38] HIRAYAMA F.Current understanding of allergic transfusion reactions: incidence,pathogenesis,laboratory tests,prevention and treatment[J]. Br J Haematol,2013, 160(4):434-444.
[39] AUBRON C,HOURMANT B,MENGUY J,et al.Transfusion-related respiratory complications in intensive care: A diagnosis challenge[J]. Transfus Clin Biol,2021,28(4):344-348.
[40] KLANDERMAN R B,WIJNBERGE M,BOSBOOM J J,et al.Differential effects of speed and volume on transfusion-associated circulatory overload: A randomized study in rats[J]. Vox Sang,2022,117(3):371-378.
[41] FADEYI O A,KERESZTES P,SAHA A K,et al.Preventing transfusion-associated circulatory overload in acute care settings[J]. Nursing,2023,53(6):37-41.
[42] BULLE E B,KLANDERMAN R B,PENDERGRAST J,et al.The recipe for TACO: A narrative review on the pathophysiology and potential mitigation strategies of transfusion-associated circulatory overload[J]. Blood Rev,2022,52:100891.
[43] WANG M,GOLDGOF G M,PATEL A,et al.Novel computational methods on electronic health record yields new estimates of transfusion-associated circulatory overload in populations enriched with high-risk patients[J]. Transfusion,2023,63(7):1298-1309.
[44] DESAI D S,SHAH K S,SHAH S A.Educational Case: Transfusion reactions: Transfusion associated circulatory overload vs transfusion-related acute lung injury[J]. Acad Pathol,2022,9(1):100022.
[45] ROUBINIAN N H,LOONEY M R,KOR D J,et al.Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions[J]. Transfusion,2015, 55(8):1838-1846.

输血相关循环超负荷临床诊治的专家共识（2026版）

Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-associated Circulatory Overload (2026 Edition)

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 12

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	梁春艳, 段莉, 刘友迎, 刘方久. 住院患者输血相关循环超负荷的危险因素及预测模型的构建与验证[J]. 临床输血与检验, 2024, 26(6): 771-776.
[2]	郭天虹, 王雨涵, Claudia SC, 黄远帅. 基于研究证据的输血医学新进展[J]. 临床输血与检验, 2023, 25(4): 572-576.
[3]	黎欢, 谢佳, 何洪伟, 彭涛, 张利, 谭强, 胡燕, 吴玲. 心脏外科围术期大量输血患者输血相关呼吸系统不良反应回顾性调查[J]. 临床输血与检验, 2023, 25(3): 358-362.
[4]	中国输血协会临床输血管理学专业委员会. 重型和危重型COVID-19患者血液成分安全输注专家共识^*[J]. 临床输血与检验, 2023, 25(2): 149-162.
[5]	杜亚丽, 张蓉, 王燕菊, 陈丽, 蒋学兵. 年轻血浆抗衰老作用及其机制研究进展^*[J]. 临床输血与检验, 2023, 25(1): 137-142.
[6]	康澜, 李世林, 杨春晖. 血液成分中病原体灭活技术及其研究进展[J]. 临床输血与检验, 2022, 24(4): 521-527.
[7]	李宏洋, 杨佶军, 成鹏, 刘铁梅. 精准化输血标本定位信息系统的应用^*[J]. 临床输血与检验, 2020, 22(3): 282-284.
[8]	郑艳梅, 高健, 柴声江. 襄阳地区临床用血工作调查分析与思考[J]. 临床输血与检验, 2019, 21(5): 471-473.
[9]	张春荣, 吴敏, 杨红梅, 张华. 血液成分集中化质量检查的可行性探讨[J]. 临床输血与检验, 2018, 20(2): 212-215.
[10]	熊永芬, 吴斌, 谭璐, 陈会欣, 王顺. 武汉地区某大型三甲医院临床用血情况调查与结构分析^*[J]. 临床输血与检验, 2017, 19(6): 547-550.
[11]	李红梅,王远杰. ICU住院患者临床输血调查^*[J]. 临床输血与检验, 2016, 18(6): 528-531.
[12]	李志强. 危重病患者个体化输血策略与管理*[J]. 临床输血与检验, 2016, 18(2): 97-100.